There are 749 resources available
Long-term results of phase II trial of reduced modified clinical target volume in low-risk nasopharyngeal carcinoma treated with intensity modulated radiotherapy
Presenter: Jingjing Miao
Session: Mini Oral session - Head and neck cancer
Resources:
Slides
Webcast
Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta Indonesia
Presenter: Susanna Hutajulu
Session: Mini Oral session - Head and neck cancer
Resources:
Slides
Webcast
Survival outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
Presenter: Filipa Pontes
Session: Mini Oral session - Head and neck cancer
Resources:
Slides
Webcast
Effects of immune architecture on response to adjuvant capecitabine in triple negative breast cancer (FinXX trial)
Presenter: Douglas Hinerfeld
Session: Proffered paper session - Breast cancer
Resources:
Slides
Webcast
Trastuzumab emtansine (T-DM1) vs trastuzumab (H) in Chinese patients (pts) with residual invasive disease after neoadjuvant chemotherapy for HER2-positive breast cancer (BC) in the phase III KATHERINE study
Presenter: Chiunsheng Huang
Session: Proffered paper session - Breast cancer
Resources:
Slides
Webcast
Subgroup analysis of IMpassion130: Atezolizumab + nab-paclitaxel (nab-P) in patients (pts) with advanced triple-negative breast cancer (TNBC) in Asian countries
Presenter: Hiroji Iwata
Session: Proffered paper session - Breast cancer
Resources:
Slides
Webcast
Talazoparib (TALA) vs physician’s choice of chemotherapy (PCT) in Asian patients (Pts) with HER2- advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCA1/2mut): Data from phase III EMBRACA
Presenter: Kyung-Hun Lee
Session: Proffered paper session - Breast cancer
Resources:
Slides
392O - Treatment outcomes of colorectal cancer patients enrolled in a comprehensive benefits program of the National Health Insurance System in the Philippines: Data from the program pilot site
Presenter: Danielle Benedict Sacdalan
Session: Mini Oral session - Public policy
Resources:
Abstract
289O - Spectrum of mitochondrial genomic variation in parathyroid neoplasms by ultra-deep targeted DNA sequencing
Presenter: Ya Hu
Session: Mini Oral session - Head and neck cancer
Resources:
Abstract
292O - 90-day mortality in head and neck cancer after concurrent chemoradiotherapy
Presenter: Szu-Yuan Wu
Session: Mini Oral session - Head and neck cancer
Resources:
Abstract